Incretin-based therapies for the treatment of obesity-related diseases
Abstract Obesity-related disability-adjusted life years (DALYs) are expected to increase by approximately 40% from 2020 to 2030. DALYs and mortality related to obesity are the consequence of multiple comorbidities such as cardiovascular (i.e., heart failure) and metabolic diseases (i.e. type 2 diabe...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Portfolio
2024-11-01
|
| Serija: | npj Metabolic Health and Disease |
| Online dostop: | https://doi.org/10.1038/s44324-024-00030-5 |
| Oznake: |
Brez oznak, prvi označite!
|